Filing Flows › Niagen Bioscience (NAGE) › Consumer Products segment revenue
Niagen Bioscience (NAGE) Consumer Products segment revenue by quarter
Niagen Bioscience's Consumer Products segment revenue was $23.3M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 6 quarters it ranged from $21.5M (Q1 2025) to $26.0M (Q3 2025).
| Quarter | Consumer Products segment revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $23.3M | -3% | -10% |
| Q2 2026 | $24.2M | +8% | +6% |
| Q1 2026 | $22.4M | -14% | +4% |
| Q3 2025 | $26.0M | +15% | — |
| Q2 2025 | $22.7M | +6% | — |
| Q1 2025 | $21.5M | — | — |
Q3 2026 at a glance
Niagen Bioscience, Q3 2026: revenue $27.2M (-20% year over year), operating margin -5.8%, net loss $1.2M, operating cash flow $2.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Niagen Bioscience's Consumer Products segment revenue?
Niagen Bioscience's Consumer Products segment revenue was $23.3M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Niagen Bioscience's Consumer Products segment revenue changed?
Over the last 6 quarters it ranged from $21.5M (Q1 2025) to $26.0M (Q3 2025).